Retirement Planning Company of New England’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Retirement Planning Company of New England's BMY Position: Q2 2026 in Review
Retirement Planning Company of New England reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2026, selling an estimated $36.8K and leaving 10,883 shares worth $627K. The position accounts for 0.23% of the portfolio, ranked #120.
Retirement Planning Company of New England first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $876K in Q2 2022. 1,973 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Retirement Planning Company of New England held 10,883 shares of Bristol-Myers Squibb worth $627K as of Q2 2026.
- Retirement Planning Company of New England sold 641 Bristol-Myers Squibb shares in Q2 2026, an estimated $36.8K.
- Bristol-Myers Squibb made up 0.23% of Retirement Planning Company of New England's portfolio in Q2 2026, its #120 holding.
- Retirement Planning Company of New England first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Retirement Planning Company of New England's Bristol-Myers Squibb position peaked at $876K in Q2 2022.
- 1,973 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Retirement Planning Company of New England's 13F filing for Q2 2026, filed 30 Jul 2026.